Topically Applied Connective Tissue Growth Factor/CCN2 Improves Diabetic Preclinical Cutaneous Wound Healing: Potential Role for CTGF in Human Diabetic Foot Ulcer Healing

Figure 1

Wound macrophage counts. (a) CTGF treated (control and diabetic groups combined) is different to CTGF untreated (control and diabetic groups combined); by unpaired -test at day 7. No statistical difference was observed between groups at day 14 (b). Results are expressed as mean ± SEM.

(a) Day 7

(b) Day 14